QIAGEN powered by

Webinars and events

Loading Events

« All Events

Interpretieren Sie somatische Varianten einfach und schnell mit HSMD

June 20, 2023 @ 10:00 am - 11:30 am

Verpassen Sie nicht die Gelegenheit, das bestgehütete Geheimnis von somatischen NGS-Tests kennenzulernen.
Die von QIAGEN entwickelte neue Datenbank namens HSMD enthält über 2 Jahrzehnte von Experten kuratierte Inhalte aus der QIAGEN Knowledge Base und Daten aus über 300.000 realen Onkologie-Fällen, um tiefgreifende Einblicke in die genaue Funktion und Handlungsfähigkeit von kleinen Varianten wie SNVs, Indels und Frameshifts zu bieten, die “klinisch beobachtet” oder aus wissenschaftlichen Publikationen kuratiert wurden.
Am 20. Juni werden unsere Experten Ihnen in einer Demonstation die neue Datenbank vorstellen und Ihnen ihre Funktionen, Fähigkeiten und Anwendungen vorstellen.
In diesem Webinar werden Sie lernen:
• Woher HSMD seine Daten zieht
• Wie Sie HSMD für verschiedene Anwendungen wie Forschung, molekulare Tests und pharmazeutische Entwicklung nutzen und anwenden können
• Wie Sie eine kostenlose, 5-tägige Testversion von HSMD für Ihr Labor erhalten können


Date: June 20, 2023
 10:00 am - 11:30 am
Register for event
Event Categories:
Event Tags:


Virtual – Germany
Register for event

On-demand Webinars

  • On-demand webinar: Get insights into the bioinformatics analysis of Nanopore sequencing data for SARS-CoV-2

    The study of the COVID-19 pandemic often involves sequencing the SARS-CoV-2 virus using Illumina, Nanopore, IonTorrent and Sanger technologies alone or in combination. Depending on the sampling and library preparation method used, this can involve metatranscriptomic data of varying viral content. In this webinar tutorial, you will learn about: Best practices for ...

  • On-demand webinar: Discover hidden relationships in your toxicological studies with QIAGEN IPA

    QIAGEN Ingenuity Pathway Analysis (IPA) reveals the hidden upstream drivers and downstream outcomes in your toxicogenomics datasets. Put those results into context using Analysis Match with over 50,000 pre-analyzed datasets for human, mouse and rat. Explain the causes and effects in your studies so you can generate hypotheses to develop better drugs, biomarkers and mo...

  • On-demand web seminar: Enabling high-throughput genomic surveillance of emerging SARS-CoV-2 strains

    Join our webinar to discover a scalable workflow for SARS-CoV-2 whole genome sequencing to accelerate detection of variants such as B.1.1.7 and B.1.351. In this new webinar, we will describe how QIAGEN’s QIAseq SARS-CoV-2 integrated workflow combines QIAseq chemistries and CLC Genomics Analysis software to deliver a scalable, high-performance solution for sequencing...

  • On-demand webinar: Investigation of Somatic and Germline Variants by COSMIC, HGMD and QIAGEN Databases

    Identifying and studying actionable variants is of great interest to many investigators. In this webinar, COSMIC, HGMD and QIAGEN database will be introduced for annotation and investigation of both somatic and germline variants. Attendees will learn how to use QIAGEN Clinical Insight Interpret Translational (QCI-IT) to identify key actionable variants from whole geno...

  • On-demand Webinar: Whole exome sequencing (WES) helps understand exceptional survival in rare sarcoma patient

    In this webinar presented by Rockefeller University, Danbury Hospital and QDI, we present a unique case study of a treatment-naïve patient with aggressive metastatic uLMS who has experienced long-term survival. Using whole exome sequencing (WES), we analyzed 5 tumors to identify mechanisms of uLMS tumor growth and metastasis in this patient. Attendees of this webi...

  • On-demand Webinar: Accelerate R&D in new cancer drug development

    Learn about a new database that helps you accelerate cancer drug development. This is the ONE tool that all translational research programs need to accelerate cancer drug R&D. Free trials offered to all attendees.   Webinar Abstract The paradigm of predictive biomarkers of therapeutic responses to drug intervention has dramatically transformed cancer...

  • On-demand Webinar: Comprehensive Molecular Tumor Analysis with Alacris Theranostics

    Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choic...